Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Heat shock protein 70–Bcl-2-associated athanogene 1M (Hsp70–BAG-1M) protein–protein interaction complex is a critical regulatory assembly in the cellular proteostasis network, comprising the molecular chaperone Heat shock protein 70 (Hsp70) and its co-chaperone Bcl-2-associated athanogene 1M (BAG-1M) (UniProt: P08107, Q99933). BAG-1M functions as a nucleotide exchange factor (NEF) that binds to the ATPase domain of Hsp70, stimulating the release of ADP and facilitating the turnover of client proteins (PMID: 11226344). This interaction plays a pivotal role in determining protein fate, linking the chaperone machinery to the ubiquitin-proteasome system to regulate whether proteins are refolded or degraded (PMID: 10675341). In many cancers, the Hsp70–BAG-1M complex is upregulated and promotes cell survival by stabilizing oncogenic signaling molecules such as Raf-1 and FoxM1 (PMID: 25564440). In neurodegenerative diseases, the complex is involved in the processing of aggregate-prone proteins like tau and alpha-synuclein (PMID: 15831476). Therapeutic strategies targeting this complex involve small-molecule inhibitors like JG-98, which allosterically disrupt the interaction to induce the degradation of pro-survival clients and trigger apoptosis in malignant cells (PMID: 25564440). However, the high conservation of Hsp70 across tissues presents significant challenges for achieving therapeutic selectivity and avoiding systemic toxicity.
Allosteric inhibition of the protein-protein interaction between the Hsp70 nucleotide-binding domain and the BAG domain of BAG-1M, which prevents nucleotide exchange, stalls the chaperone cycle, and leads to the degradation of oncogenic client proteins.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein 70–Bcl-2-associated athanogene 1M protein–protein interaction complex (Hsp70–BAG-1M complex).